NNMTi treatment‐induced cytotoxicity was confirmed in two out of three patient‐derived ccRCC ALI models, strongly corroborating the therapeutic potential of NNMT inhibition in vivo. Here, NNMT is linked to nonpapillary renal cell carcinoma.